← Leaderboards
Stefanie N. Vogel
University Of Maryland Baltimore
$26,533,913
Attributed
$32,812,992
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,812,992 · 17
By mechanism
R01$18,884,368 · 8
R37$5,336,899 · 1
T32$4,265,595 · 1
R21$1,278,763 · 3
U54$1,267,999 · 1
R41$1,068,694 · 1
Top collaborators
- Jorge C Blanco16 shared
- Achsah D. Keegan5 shared
- Rose Marie Viscardi5 shared
- Robert K Ernst2 shared
- Daniel Joseph Prantner2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Achsah D. Keegan$11,546,358
- Rose Marie Viscardi$8,090,191
- Kari Ann Shirey$411,250
- Elizabeth A Jacobsen$5,296,553
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwayMacrophageResponseCytokineMediatingInflammatoryInfectionImmune ResponsePathogenCellsLipopolysaccharidesTlr4 GeneIn VivoBaseMolecularSignal TransductionLeadVirusToll-Like ReceptorsPathway InteractionsTissuesGene ExpressionProductionIn Vitro
Grant awards (78)
Signaling Pathways in Innate Immunity$530,068
T32 · FY2025 · AI · contact PI
Signaling Pathways in Innate Immunity$525,332
T32 · FY2024 · AI · contact PI
Inducible HMGB1 antagonist for viral-induced acute lung injury.$488,080
R41 · FY2024 · HL
Methylglyoxal-induced macrophage metabolic dysregulation in sepsis$193,125
R21 · FY2024 · AI · contact PI
Inducible HMGB1 antagonist for viral-induced acute lung injury.$62,894
R41 · FY2024 · HL
Inducible HMGB1 antagonist for viral-induced acute lung injury.$29,640
R41 · FY2024 · HL
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2023 · AI
Inducible HMGB1 antagonist for viral-induced acute lung injury.$488,080
R41 · FY2023 · HL
Signaling Pathways in Innate Immunity$452,908
T32 · FY2023 · AI · contact PI
Methylglyoxal-induced macrophage metabolic dysregulation in sepsis$231,750
R21 · FY2023 · AI · contact PI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2022 · AI
RSV-induced M2 macrophage differentiation: role of TLR4/PPARg/RXR signaling axis (80)$190,063
R21 · FY2022 · AI · contact PI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2021 · AI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury$544,376
R01 · FY2021 · AI · contact PI
Macrophage differentiation and disease outcome in influenza infection$542,926
R01 · FY2021 · AI · contact PI
Signaling Pathways in Innate Immunity$420,232
T32 · FY2021 · AI · contact PI
RSV-induced M2 macrophage differentiation: role of TLR4/PPARg/RXR signaling axis (80)$241,700
R21 · FY2021 · AI · contact PI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2020 · AI
Macrophage differentiation and disease outcome in influenza infection$542,926
R01 · FY2020 · AI · contact PI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury$533,933
R01 · FY2020 · AI · contact PI
Signaling Pathways in Innate Immunity$428,098
T32 · FY2020 · AI · contact PI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury$52,216
R01 · FY2020 · AI · contact PI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2019 · AI
Macrophage differentiation and disease outcome in influenza infection$542,926
R01 · FY2019 · AI · contact PI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury$533,933
R01 · FY2019 · AI · contact PI
Signaling Pathways in Innate Immunity$416,712
T32 · FY2019 · AI · contact PI
Analysis of Cellular Metabolism using Seahhorse Technology$204,674
S10 · FY2019 · OD · contact PI
Macrophage differentiation and disease outcome in influenza infection$542,926
R01 · FY2018 · AI · contact PI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury$533,933
R01 · FY2018 · AI · contact PI
Signaling Pathways in Innate Immunity$408,060
T32 · FY2018 · AI · contact PI
Macrophage differentiation and disease outcome in influenza infection$555,603
R01 · FY2017 · AI · contact PI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury$547,143
R01 · FY2017 · AI · contact PI
Signaling Pathways in Innate Immunity$139,588
T32 · FY2017 · AI · contact PI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza$865,457
R01 · FY2016 · AI · contact PI
Signaling Pathways in Innate Immunity$174,635
T32 · FY2016 · AI · contact PI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza$865,457
R01 · FY2015 · AI · contact PI
Differentiative Signals for Macrophage Activation$506,000
R56 · FY2015 · AI · contact PI
Signaling Pathways in Innate Immunity$196,224
T32 · FY2015 · AI · contact PI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza$878,832
R01 · FY2014 · AI · contact PI
Differentiative Signals for Macrophage Activation$730,076
R01 · FY2014 · AI · contact PI
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis$230,250
R21 · FY2014 · AI
Signaling Pathways in Innate Immunity$185,558
T32 · FY2014 · AI · contact PI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza$784,554
R01 · FY2013 · AI · contact PI
Differentiative Signals for Macrophage Activation$686,272
R01 · FY2013 · AI · contact PI
Innate and adaptive immune response to Francisella tularensis$217,586
U54 · FY2013 · AI · contact PI
Signaling Pathways in Innate Immunity$194,090
T32 · FY2013 · AI · contact PI
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis$191,875
R21 · FY2013 · AI
Differentiative Signals for Macrophage Activation$730,076
R01 · FY2012 · AI · contact PI
Innate and adaptive immune response to Francisella tularensis$250,912
U54 · FY2012 · AI · contact PI
Signaling Pathways in Innate Immunity$194,090
T32 · FY2012 · AI · contact PI
Differentiative Signals for Macrophage Activation$744,976
R01 · FY2011 · AI · contact PI
Innate and adaptive immune response to Francisella tularensis$265,151
U54 · FY2011 · AI · contact PI
Differentiative Signals for Macrophage Activation$752,501
R01 · FY2010 · AI · contact PI
Innate and adaptive immune response to Francisella tularensis$272,582
U54 · FY2010 · AI · contact PI
Differentiative Signals for Macrophage Activation$113,100
R01 · FY2010 · AI · contact PI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$640,884
R37 · FY2009 · AI · contact PI
Innate and adaptive immune response to Francisella tularensis$261,768
U54 · FY2009 · AI · contact PI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$113,100
R37 · FY2009 · AI · contact PI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$622,219
R37 · FY2008 · AI · contact PI
Mechanisms and Consequences of Toll Like Receptor Signal Transduction$241,727
R01 · FY2008 · AI · contact PI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$615,797
R37 · FY2007 · AI · contact PI
Mechanisms and Consequences of Toll Like Receptor Signal Transduction$246,409
R01 · FY2007 · AI · contact PI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$615,717
R37 · FY2006 · AI · contact PI
Mechanisms and Consequences of TLR Signal Transduction$253,769
R01 · FY2006 · AI · contact PI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$627,169
R37 · FY2005 · AI
Roles of Toll Like Receptors in Innate Immunity$259,875
R01 · FY2005 · AI
Mechanisms and Consequences of TLR Signal Transduction$259,875
R01 · FY2005 · AI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$445,960
R37 · FY2004 · AI
EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS$409,863
R01 · FY2004 · AI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$432,971
R37 · FY2003 · AI
EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS$397,926
R01 · FY2003 · AI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$420,360
R37 · FY2002 · AI
EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS$386,337
R01 · FY2002 · AI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$407,292
R37 · FY2001 · AI
EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS$337,911
R01 · FY2001 · AI
EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS$37,175
R01 · FY2001 · AI
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION$395,430
R37 · FY2000 · AI
EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS$376,209
R01 · FY2000 · AI